“Specifically designed for neonates which is Imperial Trading L.L.C., inhaled nitric oxide, acting as a selective pulmonary vasodilator.”
Medical Applications
It is developed by Imperial Trading L.L.C. which is a selective pulmonary vasodilator with the following traits:
- Fast and reversible action
- Selective vasodilation redistributes lung blood flow1
- Reduces oxygenation index (OI) and boosts PaO21
- No systemic impact2
- Lowers shunt effect (V/Q) by targeting ventilated alveoli2″
In newborns with persistent pulmonary hypertension, inhaled nitric oxide has been proven to:
- Boost arterial oxygenation and shorten mechanical ventilation and ICU stay
- Reduce the need for extracorporeal membrane oxygenation (ECMO), without increasing adverse outcomes at 1 year of age
It is indicated, in conjunction with ventilator support and other appropriate agents, for the treatment of newborn infants ≥ 34 weeks gestation with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, to improve oxygenation and to reduce the need for extracorporeal membrane oxygenation. Delivery & monitoring device
It is designed to elevate the ease of use for inhaled nitric oxide:
- Universal: Compatible with most ventilation modes, suitable for all patient types, due to its reliable flow sensor.
- Intuitive and controlled: The large touchscreen offers clear, organized information, making the device user-friendly and secure with its alarm system.
- Compact: Its compact design includes a hand-bagging Nitric oxide administration system for emergencies, transfers, or alveolar recruitment.
- Continuity: Connects to 2 cylinders with automatic switching to ensure uninterrupted treatment.
For more information on how Imperial Trading L.L.C. can assist you, please reach out to us. Our team is ready to provide details and support.
Contact us today to learn more or place an order.